Prostate Cancer

The Pharmacy Times® Prostate Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancer that occurs in the prostate.

Latest News

FDA -- Image credit: wladimir1804 | stock.adobe.com
FDA Accepts sNDA for Darolutamide With ADT for Patients With mHSPC

November 21st 2024

The supplemental new drug application (sNDA) is based on results from a phase 3 trial that enrolled patients with metastatic hormone-sensitive prostate cancer (mHSPC).

Macro shot of white button mushrooms close up - Image credit: Mediaphotos | stock.adobe.com
Mushroom Supplement Displays Benefits in Slowing and Preventing Prostate Cancer

November 13th 2024

Image Credit: © Phushutter - stock.adobe.com
Apalutamide Demonstrates Efficacy After Prostate-Directed Local Therapy for nmCRPC

October 29th 2024

Human prostate cancer cells.
FDA Approves Diagnostics for Olaparib, Abiraterone Combination Therapy in Patients With BRCA-Mutated mCRPC

September 4th 2024

Prostate Cancer Diagnosis FDA | Image Credit: kenchiro168 - stock.adobe.com
FDA Grants Fast Track Designation to 64Cu-SAR-bisPSMA for Prostate Cancer Diagnosis

August 26th 2024

Latest CME Events & Activities

Advances in the Treatment of Metastatic Renal Cell Carcinoma: New Horizons in Targeted Therapies

1.0 Credit / Genitourinary Cancer, Oncology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

View More

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

View More

<12345